ARCT (arcturusrx.com) Earnings per share growth this year

Official company branding of Arcturus Corp (ARCT)

The annual EPS growth trajectory of Arcturus Therapeutics (ARCT) demonstrates the expansion of mRNA therapy and the pursuit of profitable deals with global corporations. Business efficiency is based on the management's scientific expertise and the transparency of payments from CSL. Proprietary patents for cellular drug delivery ensure long-term monetization. The current -22.30 metric determines this level of earnings per share dynamics.

ARCT (arcturusrx.com) Earnings per share growth in current year history from 07/04/2022 to 11/15/2026

Financial and market metric breakdowns for arcturusrx.com (ARCT)

- stock value and consensus price forecast:
Basic company analysis:Arcturus Corp (ARCT)
Manufactured products of Arcturus Therapeutics

Delegating vaccine development to contract organizations allows Arcturus Therapeutics (ARCT) to optimize costs while minimizing operational risks. The current value of -22.30 reflects the dynamics of earnings per share relative to last year, where any extremes in the annual EPS growth trajectory signal changes in margins and the business model's resilience to external economic challenges.

Main competitors

Earnings per share growth rate in current year Vertex Pharmaceuticals Inc. (VRTX)|ALNY (Alnylam) - Earnings growth in current year|Earnings per share growth this year INSM (Insmed)|Net earnings per share growth this year UTHR (United Therapeutics Corporation)|BMRN (BioMarin Pharmaceutical Inc.) - Earnings per share increase in current year|Earnings per share growth in current year BridgeBio BBIO|Earnings per share increase in current year BGM|Cogent Biosciences - Earnings growth in current year|Earnings per share increase in current year XERS (Xeris Biopharma)|KROS: Earnings growth in current year|Eton Pharmaceuticals Inc (ETON) - Earnings growth in current year|Earnings per share growth in current year Kamada Corp|FULC: Earnings per share increase in current year|Earnings per share growth in current year Abeona Therapeutics, Inc. (ABEO)|Net earnings per share growth this year Mereo BioPharma Group plc MREO|Earnings per share growth in current year Protalix BioTherapeutics PLX|Earnings growth in current year Pliant Therapeutics PLRX|appliedtherapeutics.com - Earnings growth in current year|Earnings per share increase in current year RNTX (Rein Therapeutics, Inc.)|GELS: Earnings growth in current year|Earnings per share growth rate in current year Aytu BioPharma, Inc. (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Earnings growth in current year|Earnings per share growth this year SRXH (SRx Health Solutions)|Net earnings per share growth this year PLRZ (Polyrizon Ltd)|AEZS - Earnings per share growth rate in current year|Earnings per share growth in current year Cyclo Therapeutics Inc. CYTH|Inozyme Pharma, Inc. (INZY) - Earnings per share growth rate in current year|RPHM: Net earnings per share growth this year|Earnings per share growth rate in current year COSCIENS Biopharma Inc